Dean Capital Management’s Zimmer Biomet ZBH Stock Holding History

Dean Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Buy	24,566 +5,038	+26%	+$462K	0.92%	55
2025 Q4	$1.76M	Buy	19,528 +1,960	+11%	+$186K	0.75%	78
2025 Q3	$1.73M	Hold	17,568	–	–	0.67%	76
2025 Q2	$1.6M	Buy	17,568 +941	+6%	+$91K	0.66%	93
2025 Q1	$1.88M	Buy	16,627 +410	+3%	+$43.9K	0.82%	48
2024 Q4	$1.71M	Buy	16,217 +2,473	+18%	+$265K	0.73%	67
2024 Q3	$1.48M	Buy	+13,744	New	+$1.5M	0.63%	92
2024 Q2	–	Sell	-9,501	Closed	-$1.25M	–	139
2024 Q1	$1.25M	Hold	9,501	–	–	0.73%	84
2023 Q4	$1.16M	Buy	9,501 +1,541	+19%	+$172K	0.71%	91
2023 Q3	$893K	Buy	+7,960	New	+$1.01M	0.67%	93
2021 Q1	–	Sell	-4,303	Closed	-$644K	–	138
2020 Q4	$644K	Sell	4,303 -267	-6%	-$37.7K	0.38%	122
2020 Q3	$604K	Sell	4,570 -1,679	-27%	-$219K	0.62%	91
2020 Q2	$724K	Buy	6,249 +678	+12%	+$78.1K	0.85%	44
2020 Q1	$547K	Buy	5,571 +219	+4%	+$28.7K	0.81%	47
2019 Q4	$778K	Buy	5,352 +70	+1%	+$9.66K	0.74%	54
2019 Q3	$704K	Sell	5,282 -219	-4%	-$28.3K	0.73%	55
2019 Q2	$629K	Buy	+5,501	New	+$644K	0.65%	79

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dean Capital Management's ZBH Position: Q1 2026 in Review

Dean Capital Management increased its Zimmer Biomet (ZBH) stake by 26% in Q1 2026, buying an estimated $462K and bringing the position to 24,566 shares worth $2.22M. The position accounts for 0.92% of the portfolio, ranked #55.

Dean Capital Management first reported a position in ZBH in Q2 2019 and has held it in 17 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Dean Capital Management held 24,566 shares of Zimmer Biomet worth $2.22M as of Q1 2026.
Dean Capital Management bought 5,038 Zimmer Biomet shares in Q1 2026, an estimated $462K.
Zimmer Biomet made up 0.92% of Dean Capital Management's portfolio in Q1 2026, its #55 holding.
Dean Capital Management first reported a position in Zimmer Biomet in Q2 2019 and has held it in 17 quarters since.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Dean Capital Management's 13F filing for Q1 2026, filed 15 May 2026.